Maxime Chénard-Poirier

Hémato-oncologue @chudequebec, Quebec City. Jeune Papa. Interests: GI cancers and early phase clinical trials. Former @royalmarsdenNHS fellow.

[Christian Dubé @cdube2026]

Très belle visite ajd au centre intégré de cancérologie de Québec ouvert le 17 mai dernier. Il s’agit du plus grand centre de cancérologie au Québec et parmi les plus grands au Canada. Un bel exemple de modernité qui peut se comparer à ce qui se fait de mieux dans le monde.

[Maxime Chénard-Poirier @MaxCPoirier]

@castonguayOnc @MF_damours @ChloeBeland1 @Gosselin_Caro @dradesnoyers @NickMarcouxMD Bravo à tous, superbes présentations de la part de nos résidents et de @dradesnoyers!

[Maxime Chénard-Poirier @MaxCPoirier]

@tehfem @chumontreal @med_umontreal @UMontreal Félicitations Mustapha!

[Hagen Kennecke @HKennecke]

#GI22 GALAXY results support the use of post-op chemo in #CtDNA➕stage I-IV #colorectalcancer and shows good outcomes regardless of chemo in ctDNA➖ . Results support the ongoing COBRA and CIRCULATE trials. ⁦@OncoAlert⁩ ⁦@ASCO⁩ ⁦@pashtoonkasi⁩ ⁦@SWOG⁩

[Joao Fogacci @FogacciJoao]

💡Practice change➡️ Stage III CRC

📌 Supporting what some of us have been doing in CRC adjuvant setting❗️

✅ In stage III CRC stopping ALL chemotherapy before 6 months is bad
✅ But we can safely stop OXA in 3 months (at least 50% OXA must be done)

[Vivek Subbiah, MD @VivekSubbiah]

KIT+ MEK inhibition in GIST ➡️Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor
⭐️The best ORR was 69.0% @WTapMD @JTrentMDPhD @JCO_ASCO
https://t.co/4EKyGH0TsZ

[Dr. Nina Niu Sanford @NiuSanford]

#GI22: PD-1 blockade alone for dMMR locally advanced rectal cancer

@LumishMelissa et al, NCT04165772

Stage II-III dMMR LARC treated with anti-PD-1 alone x 6 months.

All N=12 patients responding (ORR=100%) & 7/7 (100%) completing 6 mo. of treatment achieved cCR!

[Faculté de médecine – Université Laval @facmedUL]

Comment prendre soin du cœur des femmes? Assistez à notre prochain Grand rendez-vous en santé avec la professeure @facmedUL, cardiologue et chercheuse @IUCPQ Marie-Ève Piché. Détails et inscription: https://t.co/uaOF7DlK15

[CATALIS QUÉBEC @catalisquebec]

François Laviolette, pilier de la recherche en IA, nous a quittés. Membre du Comité aviseur patient de CATALIS, il aura apporté lumière et sagesse sur la valorisation des données de recherche. Sa mémoire continuera d’inspirer notre milieu. Merci et bon repos François.

[Maxime Chénard-Poirier @MaxCPoirier]

Impressive data! Hopefully will lead to an OS benefit #gcsm https://t.co/gEMMK7MuRl

[Raghav Sundar @sundar__raghav]

Pleased to present data that most GI oncologists have been asking for, but not gotten so far: role of Nivolumab in CPS 1-4 gastric cancer. https://t.co/H9q5xEUSxZ
Answer: Minimum to none.
EMA has restricted approval to only CPS >= 5. What about FDA?

[Milind Javle @JavleMilind]

https://t.co/k3b7KQdMNK Final Survival Results

[Family Guy @FamilyGuyonFOX]

Watch the new #FamilyGuy Short! Stewie and Brian travel inside Peter’s body to explain how vaccines work.

Have questions about the COVID-19 vaccines? Visit https://t.co/Yz9vi7AYYD for the most accurate and timely facts so we can all get back to the moments we love and miss most.

[Maxime Chénard-Poirier @MaxCPoirier]

Impressive activity of CLDN18.2 targeted CAR-T in pretreated gastric cancer presented by Dr Qi. Quite nice to see CAR-T moving more and more in the solid tumor field. We need more of these! #ESMO2021 #gcsm

[Maxime Chénard-Poirier @MaxCPoirier]

Wee1 inhibition is making headway in CRC. PFS benefit with OS only in left-sided, but early days data. #ESMO2021 #crcsm

[Marcelle Goldner Cesca @CescaGoldner]

Metastasectomy appears to improve OS for mGC/GEJC, even when compared to a good prognosis non-metastasectomy subgroup. This approach should be considered whenever reasonable.
#WorldGI2021

[Maxime Chénard-Poirier @MaxCPoirier]

@RamiNassabein Félicitations Rami!

[Razelle Kurzrock, MD @Dr_R_Kurzrock]

Mutation hot spots may not be targets because
1. They are passengers
2. They are produced repeatedly because of specific signatures such as APOBEC, rather than by selection
3. They are silenced at the RNA level

[Maxime Chénard-Poirier @MaxCPoirier]

@tehfem Un brin dystopique, à la Brave New World

[Maxime Chénard-Poirier @MaxCPoirier]

@haldol Excellente nouvelle! Surtout dans le contexte où c’est pas tout les travailleurs de la santé qui sont vaccinés, malheureusement...